Estudio comparativo entre tratamiento hormonal vs tratamiento hormonal + metformina en pacientes con Síndrome de Ovario Poliquístico en el Hospital General del Norte de Guayaquil Ceibos 2017-2019.

Abstract

Polycystic ovarian syndrome (PCOS) is called as the condition characterized by the presence of ovaries with cysts variable in size, accompanied by amenorrhea, hyperandrogenism, and obesity. Its diagnosis is based on various consensus, with the Rotterdam criteria being the most widely used. The objective of this study is to determine the evaluation of hormonal treatment vs. hormonal treatment + metformin in patients with polycystic ovary syndrome. The research work is a retrospective, observational and analytical study, which includes a total of 99 patients with polycystic ovary syndrome, sometimes a treatment at the Hospital General del Norte de Guayaquil Los Ceibos during the period of April 2017 - April 2019. From the patients attended, it was obtained that, when evaluating the evaluation of the treatment, specifically of the type, the follicles decrease significantly (F (1, 97) = 4.65; p = 0.034). By measuring each treatment, the regulation of the menstrual cycle is obtained and the decrease in the number of follicles are independent of the type of treatment, so it was linked that the regulation of the cycle had no influence on the part of the treatment but because of the decrease in the number of follicles. Regarding risk factors, BMI was found to be associated with a greater number of clients, and they decreased affected by the type of treatment at 3 months; neither BMI nor age influence the regularity of the menstrual cycle, specifically the treatment .